Eli Lilly on Thursday launched in India its diabetes and weight-loss drug, Mounjaro, which has already clocked in over $20 ...

Here are the local and international drugmakers also eyeing the Indian market and looking to introduce rivals to Lilly's drug ...

Kazakhstan's oil output has reached a record high this month on the back of oilfield expansion, further exceeding OPEC+ production quotas, two industry sources said and Reuters calculations showed on ...

Wegovy and Lilly’s Mounjaro belong to the same class of ... Brazil, Mexico, and Saudi Arabia. India’s Zydus Lifesciences is developing the generic version of Semaglutide and plans on launching ...

Some early evidence also suggests GLP-1-based weight-loss drugs such as Wegovy, Ozempic, Mounjaro, and Zepbound might also make ... which is based in Saudi Arabia (one of the largest funders of aging ...

Read Trump’s full post Timing: Several Trump administration officials are set to meet with their Ukrainian counterparts in Saudi Arabia next ... drugs Zepbound and Mounjaro,” reports The ...

Amy Schumer endorses the new weight loss drug Mounjaro, praising its effectiveness after an adverse experience with Wegovy. Mounjaro is an injectable medication for type 2 diabetes known for its ...

Mounjaro, a new treatment for Type 2 diabetes and obesity, has been launched in India after CDSCO approval. The drug, developed by Eli Lilly and Company, targets both GIP and GLP-1 receptors ...

Eli Lilly weight loss drug: Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. (Representative Image) Eli Lilly weight loss drug ...

Eli Lilly and Company (India) on Thursday announced the launch of its globally popular weight-loss injectable drug, Mounjaro, in India. Adults taking the drug with diet and exercise in a ...